Our IVM and radiolabel biodistribution studies revealed the mechanistic basis of the TI improvement, providing evidence that decreasing the affinity of the ADC reduced the TMDD to MET expressed in normal tissues (while maintaining sufficient uptake of the ADC), as well as delivery of the payload to tumor which over-expresses MET, likely due to avidity. Here, MET is linked to neoplasm.